Table of Content


Introduction
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Overview
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Therapeutics Development
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Therapeutics Assessment
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Companies Involved in Therapeutics Development
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Drug Profiles
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Dormant Projects
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Discontinued Products
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Clostridioides difficile Infections (Clostridium difficile Associated Disease), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Clostridioides difficile Infections (Clostridium difficile Associated Disease), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Products under Development by Companies, H1 2020 (Contd..4), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Absynth Biologics Ltd, H1 2020
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Acurx Pharmaceuticals LLC, H1 2020
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Appili Therapeutics Inc, H1 2020
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Artugen Therapeutics Ltd, H1 2020